Can Nexplanon (etonogestrel subdermal implant) cause heavy menstrual bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Nexplanon Cause Heavy Bleeding?

Yes, Nexplanon can cause heavy bleeding, though this is uncommon—occurring in approximately 7-18% of users depending on the study—while most women experience lighter or infrequent bleeding patterns. 1

Understanding Bleeding Patterns with Nexplanon

What to Expect

The CDC guidelines explicitly state that heavy or prolonged bleeding, whether unscheduled or menstrual, is uncommon during implant use, but bleeding irregularities of some type are the norm rather than the exception 1. The most common patterns include:

  • Amenorrhea (no bleeding): 22% of users 1
  • Infrequent spotting: 34% of users 1
  • Frequent bleeding: 7% of users 1
  • Prolonged bleeding: 18% of users 1

The FDA label confirms that changes in menstrual bleeding patterns are the most common side effect, with one out of ten women stopping use due to unfavorable bleeding changes 2.

Clinical Significance

These bleeding changes are generally not harmful and do not require medical treatment unless they are bothersome to the patient 1. The bleeding pattern experienced during the first three months broadly predicts future patterns for many women, though approximately 50% of those with unfavorable initial patterns will see improvement 1.

When Heavy Bleeding Occurs: Clinical Approach

Rule Out Other Causes First

If a patient reports heavy or prolonged bleeding, the CDC recommends considering underlying gynecological problems including 1:

  • Drug interactions with medications that may affect bleeding
  • Sexually transmitted infections
  • Pregnancy (including ectopic pregnancy)
  • New pathologic uterine conditions such as polyps or fibroids

Treatment Options

If no underlying problem is found and the woman desires treatment, the following evidence-based options can be offered during bleeding days 1:

First-line treatment:

  • NSAIDs for 5-7 days (short-term treatment) 1
    • Mefenamic acid 500 mg three times daily for 5 days has shown significant bleeding cessation within 7 days 1
    • Celecoxib 200 mg daily for 5 days also demonstrated efficacy 1

Second-line treatment (if medically eligible):

  • Low-dose combined oral contraceptives for 10-20 days (short-term treatment) 1
  • Estrogen alone for 10-20 days (short-term treatment) 1

Recent evidence from 2025 shows that norethisterone acetate 10 mg daily effectively stops prolonged bleeding in 86.7% of users within 7 days, though bleeding recurrence is common (median 5 days after stopping treatment) 3.

Discontinuation Considerations

If irregular bleeding persists despite treatment and the woman finds it unacceptable, counsel her on alternative contraceptive methods and offer another method if desired 1. In clinical trials:

  • 11-13% of women discontinued due to bleeding irregularities 1, 4
  • Heavy or prolonged bleeding caused 18 subjects to withdraw in one long-term study 5
  • Irregular bleeding (10.8%) was the single most common reason for discontinuation, while amenorrhea (0.3%) was cited less frequently 6

Critical Counseling Points

Pre-insertion Counseling is Essential

Before implant insertion, provide comprehensive counseling about potential bleeding pattern changes 1. Enhanced counseling about expected bleeding patterns and reassurance that irregularities are generally not harmful has been shown to reduce discontinuation rates 1.

Predictive Factors

Women with historically irregular menses or those seeking the implant specifically for menstrual management are more likely to report bothersome bleeding 7. Conversely, prior use of progestin injection or implant is associated with lower odds of bleeding complaints 7.

Common Pitfall

Do not assume heavy bleeding is always implant-related. The guidelines emphasize that abnormal bleeding should be evaluated as needed to exclude pathologic conditions or pregnancy 1, 2. Failure to investigate can lead to missed diagnoses of serious conditions like ectopic pregnancy, which may be slightly more likely in the rare event of contraceptive failure 2.

References

Research

The effects of Implanon on menstrual bleeding patterns.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2008

Research

A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 1999

Research

Contraceptive Implant-Associated Bleeding in Adolescent/Young Adult Clinical Practice: Associated Factors, Management, and Rates of Discontinuation.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.